Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

Abstract

Introduction. Sign and symptoms of rheumatoid arthritis have circadian rhythms and are more prominent in the morning. Timing of glucocorticoid administration may be important with respect to the natural secretion of endogenous glucocorticoids. Herein, we intended to test the hypothesis that bedtime administration of prednisolone could be more efficient in controlling signs and symptoms in patients with RA. Material and Methods. Sixty patients with stable disease were treated with single dose prednisolone at 8 a.m. for the first three months and thereafter with similar dose at 10 PM for the next three months (before-after method). We compared fatigue scores, morning stiffness and pain scores, Clinical Disease Activity Indices, erythrocyte sedimentation rates, C Reactive Protein, and profile of adverse effects. Results. The mean of morning stiffness, fatigue scores, CRP and CDAI decreased statistically when prednisolone was administrated at 10 p.m. The means of pain scores and ESR were also decreased when the patients took prednisolone at night, without significant statistical difference. Conclusion. Administration of low-dose oral prednisolone could reduce disease activity scores in morning in clinically stable patients with RA. So it could be supposed that administrating bedtime prednisolone may permit the smallest possible dose.

Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects

“…Additionally, the impact of circadian rhythm on metabolite levels was strongly emphasizing the importance of time of the day-specific sampling and comparisons. Providing circadian rhythm-based glucocorticoid administration already helps to improve therapy and reduce side effects especially in long-term treatment 73 74 . A denser time series might allow detection of additional fine regulations.…”

Circadian rhythms in rheumatology - a glucocorticoid perspective

“…Several studies had suggested a greater effect of bedtime or night doses (2:00 a.m.) in comparison with morning doses of conventional prednisone on morning stiffness [ 34 , 41 - 43 ]. However, a regimen that requires regular waking of the patient at 2:00 a.m. was considered impractical for the therapeutic routine.…”

Glucocorticoids in COVID19; a friend not foe

“…Hence, administering GCs with long intervals (IV pulsed and/or oral alternate doses), short-term use (two to three weeks), and recruiting short half-life GCs (e.g., prednisone), and proper timing according to our study and years of experience. [ 14 15 ]…”